This document discusses best practices in design of experiments (DOE). It covers the history and principles of DOE developed by Ronald Fisher. Case studies demonstrate how definitive screening designs can identify important factors in one step when three or fewer are important, or can be augmented when more factors are important. Optimal designs allow investigation of constrained factor spaces. A holistic approach considers customer preferences in addition to technical factors.
Solvents, not grouped in Class-1, Class-2 and Class-3, are often required to attain desirable properties of drug substances, products and excipients. Their use is particularly important in drug substances where a specific polymorph determines the bioavailability of drug product. How the limit of of such solvents is determined in pharmaceuticals, is the topic and content of this video. Further what other strategies are made available to regulatory personnel to justify such solvents' limits in pharmaceuticals.
This document outlines stability testing recommendations for different drug formulations, including whether acid-base, oxidative, photo-stability, thermal, or thermal-humidity testing is necessary or optional. It also describes how forced degradation studies are used to evaluate drug substance and product stability in various conditions, identify possible degradation pathways and products, and facilitate improvements to manufacturing and formulations.
This document discusses the design of experiments methodology. It begins by outlining the general research process and different approaches to experimentation such as trial and error, one factor at a time, and design of experiments. It then provides more details on design of experiments, including why it is used, important terminology, examples, different types of designs, and software for designing experiments. The document guides the reader through the process of designing an experiment using Response Surface Methodology and the Design-Expert software package.
Best techniques to control Genotoxities and impact of ICH M7 guidelineBhaswat Chakraborty
This document discusses best techniques to control genotoxic impurities according to the ICH M7 guideline. It covers the scope and principles of ICH M7, including risk assessment of potential genotoxic impurities in drug substances and products. It also discusses classification of impurities, acceptable intake levels, control options, and retrospective application of ICH M7 to marketed products. The goal is to limit risk from genotoxic impurities to virtually safe levels through appropriate testing, control, and documentation strategies.
This document provides an overview of how to conduct a design of experiments (DOE). It explains that a DOE tests multiple factors at once to reduce the number of tests compared to testing each factor individually. A factor is an input that can change the output when varied. Different types of test arrays are described, including full factorial arrays and fractional arrays. It is important to select the appropriate array based on the number of factors. The document also discusses analyzing the results using ANOVA to determine significant factors and interactions between factors. It emphasizes the importance of conducting a confirmation run to validate the results of the DOE.
Related Substances-Method Validation-PPT_slideBhanu Prakash N
This document provides an overview of analytical method validation. It defines validation as demonstrating a method is suitable for its intended purpose. Key validation characteristics discussed include precision, accuracy, specificity, linearity, range, detection limit, quantitation limit, ruggedness and robustness. The document describes the methodology for evaluating each characteristic, such as spiking known concentrations of analytes and establishing acceptance criteria. It emphasizes that validation confirms a method consistently produces results meeting pre-defined standards of quality.
Decentralized Clinical Trials: Collaboration to Accelerate AdoptionCraig Lipset
The document discusses decentralized clinical trials (DCT) and the need for collaboration to accelerate their adoption. It defines DCT and outlines their 17-year history prior to the COVID-19 pandemic accelerating their use. In 2020, surveys found most sponsors and CROs increasing DCT and most participants experiencing changes due to the pandemic. The document advocates for pairing the right decentralized methods and tools to each study and identifies barriers to adoption like regulatory issues. It proposes a Decentralized Trials & Research Alliance to enable collaboration and proposes meta-collaboration across initiatives to streamline efforts and avoid redundancy.
Solvents, not grouped in Class-1, Class-2 and Class-3, are often required to attain desirable properties of drug substances, products and excipients. Their use is particularly important in drug substances where a specific polymorph determines the bioavailability of drug product. How the limit of of such solvents is determined in pharmaceuticals, is the topic and content of this video. Further what other strategies are made available to regulatory personnel to justify such solvents' limits in pharmaceuticals.
This document outlines stability testing recommendations for different drug formulations, including whether acid-base, oxidative, photo-stability, thermal, or thermal-humidity testing is necessary or optional. It also describes how forced degradation studies are used to evaluate drug substance and product stability in various conditions, identify possible degradation pathways and products, and facilitate improvements to manufacturing and formulations.
This document discusses the design of experiments methodology. It begins by outlining the general research process and different approaches to experimentation such as trial and error, one factor at a time, and design of experiments. It then provides more details on design of experiments, including why it is used, important terminology, examples, different types of designs, and software for designing experiments. The document guides the reader through the process of designing an experiment using Response Surface Methodology and the Design-Expert software package.
Best techniques to control Genotoxities and impact of ICH M7 guidelineBhaswat Chakraborty
This document discusses best techniques to control genotoxic impurities according to the ICH M7 guideline. It covers the scope and principles of ICH M7, including risk assessment of potential genotoxic impurities in drug substances and products. It also discusses classification of impurities, acceptable intake levels, control options, and retrospective application of ICH M7 to marketed products. The goal is to limit risk from genotoxic impurities to virtually safe levels through appropriate testing, control, and documentation strategies.
This document provides an overview of how to conduct a design of experiments (DOE). It explains that a DOE tests multiple factors at once to reduce the number of tests compared to testing each factor individually. A factor is an input that can change the output when varied. Different types of test arrays are described, including full factorial arrays and fractional arrays. It is important to select the appropriate array based on the number of factors. The document also discusses analyzing the results using ANOVA to determine significant factors and interactions between factors. It emphasizes the importance of conducting a confirmation run to validate the results of the DOE.
Related Substances-Method Validation-PPT_slideBhanu Prakash N
This document provides an overview of analytical method validation. It defines validation as demonstrating a method is suitable for its intended purpose. Key validation characteristics discussed include precision, accuracy, specificity, linearity, range, detection limit, quantitation limit, ruggedness and robustness. The document describes the methodology for evaluating each characteristic, such as spiking known concentrations of analytes and establishing acceptance criteria. It emphasizes that validation confirms a method consistently produces results meeting pre-defined standards of quality.
Decentralized Clinical Trials: Collaboration to Accelerate AdoptionCraig Lipset
The document discusses decentralized clinical trials (DCT) and the need for collaboration to accelerate their adoption. It defines DCT and outlines their 17-year history prior to the COVID-19 pandemic accelerating their use. In 2020, surveys found most sponsors and CROs increasing DCT and most participants experiencing changes due to the pandemic. The document advocates for pairing the right decentralized methods and tools to each study and identifies barriers to adoption like regulatory issues. It proposes a Decentralized Trials & Research Alliance to enable collaboration and proposes meta-collaboration across initiatives to streamline efforts and avoid redundancy.
This document summarizes the determination of residual solvents in pharmaceuticals by gas chromatography according to ICH guidelines. Residual solvents are organic chemicals used in manufacturing that are not fully removed and may pose health risks. They are classified into Class 1, 2, or 3 based on toxicity, with Class 1 solvents prohibited. Gas chromatography with headspace injection and flame ionization detection is the primary analytical method. It involves using capillary columns, temperature programs, and identifies solvents by comparing retention times to standards. The document outlines accepted chromatographic conditions and procedures A, B, and C described in pharmacopeias.
This document discusses analytical method validation. It provides definitions and guidelines for validating analytical methods from regulatory agencies. Key aspects of method validation discussed include accuracy, precision, specificity, range, linearity, limits of detection and quantification. Validation parameters are described for different types of analytical tests including identification, quantitative impurity tests and assays. Guidelines are provided for qualifying analytical instrumentation and categorizing instruments based on complexity.
The dissolution test is an important means of assuring the continuing performance of non-solution orally administered drug products. The development of a dissolution test procedure is briefly discussed in USP general information chapter In Vitro and In Vivo Evaluation of Dosage Forms 1088, whereas general information chapter Validation of Compendial Procedures 1225 gives limited validation information for dissolution testing. Neither of these two chapters provides a level of detail and focus sufficient for dissolution testing. In 2001, a Stimuli article provided an initial rationale and discussion of content for a new general information chapter. The new chapter, The Dissolution Procedure: Development and Validation 1092, was intended to supplement the information in 1088 and 1225 and provided step-by-step detail for development and validation as well as offering information on new technology and equipment. In 2006, the chapter became official with the Second Supplement to USP 29–NF 24 (2–4).
The General Chapters—Dosage Forms Expert Committee 2010–2015 placed the review and possible revision of The Dissolution Procedure: Development and Validation 1092 on its work plan for the 2010–2015 revision cycle (2011) .
Drug Regulations has prepared this presentation based on the proposed chapter.
USP 621 Allowable Adjustment to Chromatography HPLC MethodsSandy Simmons
Effective August 1st 2014, the United States Pharmacopoeia (USP) published the latest revision to General Chapter <621> mapping out the "allowable adjustments" that can be made to USP methods without having to re-validate these methods. Articles provided by industry leaders in separation sciences, pharmacology and chemistry.
Analysis of elemental impurities in APIDr. Amsavel A
The document discusses guidelines for controlling elemental impurities in active pharmaceutical ingredients (APIs) according to new regulatory requirements. It provides an overview of:
1) Background guidelines from various regulatory agencies on limiting elemental impurities.
2) Reasons for the new requirements to replace heavy metal testing, including difficulties with reproducibility and safety of current methods.
3) Classification of elemental impurities based on toxicity and permissible intake limits set by the ICH.
It also outlines procedures for method development, validation, and implementation of elemental impurity testing and control as defined in USP general chapters 232 and 233.
ICH Q3 (A) IMPURITIES IN NEW DRUG SUBSTANCESmahrukhmughal1
This document provides guidance on reporting and controlling impurities in new drug substances. It discusses the classification, identification, and qualification of organic, inorganic, and residual solvent impurities. Key points covered include identification thresholds for impurities, qualification thresholds, reporting thresholds, analytical procedures for detecting impurities, and reporting impurity levels in batches. The document also describes how to list impurities in specifications and evaluate impurities using a decision tree when thresholds are exceeded.
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...JMP software from SAS
Learn about best practises in the
design of experiments and a data-driven approach to DOE that increases robustness, efficiency and effectiveness. This was presented at a JMP seminar in the UK.
This document provides instructions for operating a Shimadzu HPLC instrument and software. It details the instrument specifications, operation of components like the detector, pump, and column oven. It also describes how to set up the software, perform a system check, set method parameters, monitor the analysis, and integrate peaks from a chromatogram. The goal is to demonstrate basic HPLC operation and perform a single sample analysis.
This document discusses Process Analytical Technology (PAT). It begins with an introduction to PAT, defining it as a system to design, analyze, and control manufacturing through timely measurements of critical quality attributes. It then discusses how PAT works by selecting a suitable PAT system and identifying critical process parameters. It highlights some key benefits of PAT such as improving process understanding and control, enhancing safety, and reducing variation. The document also provides examples of common PAT applications and discusses regulatory guidance around implementing PAT from agencies like the FDA.
This document discusses guidelines for assessing elemental impurities in pharmaceutical products according to ICH Q3D. It describes a risk-based approach to evaluating potential sources of elemental impurities from drug substances, excipients, equipment and processing aids. Specific approaches are provided for assessing impurities from metal catalysts, water sources, and packaging materials. The presentation emphasizes controlling impurities through an understanding of manufacturing processes and applying appropriate testing and control strategies.
Experimental methods are widely used in industrial settings and research activities. In industrial settings, the main goal is to extract the maximum amount of unbiased information regarding the factors affecting production process form few observations, whereas in research, ANOVA techniques are used to reveal the reality. Drawing inferences from the experimental result is an important step in design process of product. Therefore, proper planning of experimentation is the precondition for accurate conclusion drawn from the experimental findings. Design of experiment is powerful statistical tool introduced by R.A. Fisher in England in the early 1920 to study the effect of different parameters affecting the mean and variance of a process performance characteristics
Taguchi's orthogonal arrays are highly fractional orthogonal designs. These designs can be used to estimate main effects using only a few experimental runs.
Consider the L4 array shown in the next Figure. The L4 array is denoted as L4(2^3).
L4 means the array requires 4 runs. 2^3 indicates that the design estimates up to three main effects at 2 levels each. The L4 array can be used to estimate three main effects using four runs provided that the twthree-factoro factor and three factor interactions can be ignored.
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)Teck Nam Ang
This set of slides explains in a simple manner the purpose of experiment, various strategies of experiment, how to plan and design experiment, and the handling of experimental data.
This document is intended to provide guidance for registration applications on the content and qualification of impurities in new drug substances produced by chemical syntheses and not previously registered in a region or member state.
Impurities in drug substance (ich q3 a)Bhanu Chava
This document discusses guidelines for classifying, reporting, controlling, and qualifying impurities in new drug substances. It defines types of impurities and provides thresholds for reporting, identifying, and qualifying impurities. The key points are:
- Impurities are classified as organic, inorganic, or residual solvents. Organic impurities can arise from starting materials, byproducts, or degradation.
- Identification thresholds determine which impurities must be identified and qualified. Impurities above reporting thresholds must be reported.
- Specifications list individual specified impurities and general limits for unspecified impurities.
- Qualification involves evaluating safety data for impurities at specified levels. Impurities may need further study if usual qualification thresholds
The document discusses key aspects of change control processes. It describes calculating theoretical, actual, and practical yields. It also covers reviewing production records before batch release and investigating discrepancies. Finally, it outlines the types, levels of approval, and steps of the change control process, including documenting requests, assessing impacts, planning implementation, and verifying changes.
The document discusses two examples of early experiments involving design of experiments principles:
1) During World War II, scientists simplified the complex factors involved in explosive detonation down to a cylinder expansion test with standardized materials and measurements to better study the fundamental mechanisms.
2) In 1747, James Lind conducted a controlled experiment providing different dietary supplements to groups of scurvy patients, finding those given oranges and lemons recovered while others did not, identifying citrus as a cure for scurvy. However, the experiment was not fully randomized and some treatments lacked scientific basis.
The document provides an overview of design of experiments (DOE) and factorial experiments. It defines key terms like factors, levels, treatments, responses, and noise. It explains the objectives of conducting experiments and the different types of experiments. It provides examples of 2-factor and 3-factor factorial experiments and how to analyze them. It discusses the principles of replication, randomization, and blocking. Finally, it demonstrates how to set up and analyze a general full factorial design with factors having more than two levels.
The document discusses ICH Q3D guidelines for controlling elemental impurities in pharmaceutical products. It defines elemental impurities as metals that have no therapeutic benefit and should be limited. The guidelines establish permitted daily exposures for 24 elements of concern and provide a risk-based approach to control impurities. Elements are classified based on their toxicity into Classes 1-3. The risk assessment process identifies potential sources of impurities and evaluates predicted levels. Control methods include modifying manufacturing processes, establishing specifications limits for materials and products, and selecting appropriate container systems. The guidelines provide options to convert permitted daily exposures into concentration limits for individual components and finished products.
The document discusses guidelines for controlling elemental impurities in pharmaceutical products according to ICH Q3D. It provides information on:
- Common sources of elemental impurities in drug products
- Classification of elements into categories based on their toxicity and likelihood of occurrence
- Methods for establishing permitted daily exposures (PDEs) for elements
- A risk-based approach to assessing and controlling elemental impurities that includes identifying potential sources, evaluating levels compared to PDEs, and documenting control plans
- Options for converting PDEs into concentration limits in drug products or components
The guidelines aim to replace qualitative heavy metal limits with quantitative control of specific elemental impurities shown to have no therapeutic benefit. Manufacturers must
FDA’s emphasis on quality by design began with the recognition that increased testing does not improve product quality (this has long been recognized in other industries).In order for quality to increase, it must be built into the product. To do this requires understanding how formulation and manufacturing process variables influence product quality.Quality by Design (QbD) is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.
This presentation - Part VI in the series- deals with the concepts of Design of Experiments. This presentation was compiled from material freely available from FDA , ICH , EMEA and other free resources on the world wide web.
Everything You Wanted to Know About Definitive Screening DesignsJMP software from SAS
An introduction to definitive screening designs (DSDs). These slides describe issues with standard screening designs and how to overcome these issues by using DSDs and orthogonally blocked DSD, first introduced by Bradley Jones of SAS and Christopher Nachtsheim of the Carlson School of Management, University of Minnesota. For information about using JMP software for design of experiments and DSDs, see http://www.jmp.com/applications/doe/
This document summarizes the determination of residual solvents in pharmaceuticals by gas chromatography according to ICH guidelines. Residual solvents are organic chemicals used in manufacturing that are not fully removed and may pose health risks. They are classified into Class 1, 2, or 3 based on toxicity, with Class 1 solvents prohibited. Gas chromatography with headspace injection and flame ionization detection is the primary analytical method. It involves using capillary columns, temperature programs, and identifies solvents by comparing retention times to standards. The document outlines accepted chromatographic conditions and procedures A, B, and C described in pharmacopeias.
This document discusses analytical method validation. It provides definitions and guidelines for validating analytical methods from regulatory agencies. Key aspects of method validation discussed include accuracy, precision, specificity, range, linearity, limits of detection and quantification. Validation parameters are described for different types of analytical tests including identification, quantitative impurity tests and assays. Guidelines are provided for qualifying analytical instrumentation and categorizing instruments based on complexity.
The dissolution test is an important means of assuring the continuing performance of non-solution orally administered drug products. The development of a dissolution test procedure is briefly discussed in USP general information chapter In Vitro and In Vivo Evaluation of Dosage Forms 1088, whereas general information chapter Validation of Compendial Procedures 1225 gives limited validation information for dissolution testing. Neither of these two chapters provides a level of detail and focus sufficient for dissolution testing. In 2001, a Stimuli article provided an initial rationale and discussion of content for a new general information chapter. The new chapter, The Dissolution Procedure: Development and Validation 1092, was intended to supplement the information in 1088 and 1225 and provided step-by-step detail for development and validation as well as offering information on new technology and equipment. In 2006, the chapter became official with the Second Supplement to USP 29–NF 24 (2–4).
The General Chapters—Dosage Forms Expert Committee 2010–2015 placed the review and possible revision of The Dissolution Procedure: Development and Validation 1092 on its work plan for the 2010–2015 revision cycle (2011) .
Drug Regulations has prepared this presentation based on the proposed chapter.
USP 621 Allowable Adjustment to Chromatography HPLC MethodsSandy Simmons
Effective August 1st 2014, the United States Pharmacopoeia (USP) published the latest revision to General Chapter <621> mapping out the "allowable adjustments" that can be made to USP methods without having to re-validate these methods. Articles provided by industry leaders in separation sciences, pharmacology and chemistry.
Analysis of elemental impurities in APIDr. Amsavel A
The document discusses guidelines for controlling elemental impurities in active pharmaceutical ingredients (APIs) according to new regulatory requirements. It provides an overview of:
1) Background guidelines from various regulatory agencies on limiting elemental impurities.
2) Reasons for the new requirements to replace heavy metal testing, including difficulties with reproducibility and safety of current methods.
3) Classification of elemental impurities based on toxicity and permissible intake limits set by the ICH.
It also outlines procedures for method development, validation, and implementation of elemental impurity testing and control as defined in USP general chapters 232 and 233.
ICH Q3 (A) IMPURITIES IN NEW DRUG SUBSTANCESmahrukhmughal1
This document provides guidance on reporting and controlling impurities in new drug substances. It discusses the classification, identification, and qualification of organic, inorganic, and residual solvent impurities. Key points covered include identification thresholds for impurities, qualification thresholds, reporting thresholds, analytical procedures for detecting impurities, and reporting impurity levels in batches. The document also describes how to list impurities in specifications and evaluate impurities using a decision tree when thresholds are exceeded.
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...JMP software from SAS
Learn about best practises in the
design of experiments and a data-driven approach to DOE that increases robustness, efficiency and effectiveness. This was presented at a JMP seminar in the UK.
This document provides instructions for operating a Shimadzu HPLC instrument and software. It details the instrument specifications, operation of components like the detector, pump, and column oven. It also describes how to set up the software, perform a system check, set method parameters, monitor the analysis, and integrate peaks from a chromatogram. The goal is to demonstrate basic HPLC operation and perform a single sample analysis.
This document discusses Process Analytical Technology (PAT). It begins with an introduction to PAT, defining it as a system to design, analyze, and control manufacturing through timely measurements of critical quality attributes. It then discusses how PAT works by selecting a suitable PAT system and identifying critical process parameters. It highlights some key benefits of PAT such as improving process understanding and control, enhancing safety, and reducing variation. The document also provides examples of common PAT applications and discusses regulatory guidance around implementing PAT from agencies like the FDA.
This document discusses guidelines for assessing elemental impurities in pharmaceutical products according to ICH Q3D. It describes a risk-based approach to evaluating potential sources of elemental impurities from drug substances, excipients, equipment and processing aids. Specific approaches are provided for assessing impurities from metal catalysts, water sources, and packaging materials. The presentation emphasizes controlling impurities through an understanding of manufacturing processes and applying appropriate testing and control strategies.
Experimental methods are widely used in industrial settings and research activities. In industrial settings, the main goal is to extract the maximum amount of unbiased information regarding the factors affecting production process form few observations, whereas in research, ANOVA techniques are used to reveal the reality. Drawing inferences from the experimental result is an important step in design process of product. Therefore, proper planning of experimentation is the precondition for accurate conclusion drawn from the experimental findings. Design of experiment is powerful statistical tool introduced by R.A. Fisher in England in the early 1920 to study the effect of different parameters affecting the mean and variance of a process performance characteristics
Taguchi's orthogonal arrays are highly fractional orthogonal designs. These designs can be used to estimate main effects using only a few experimental runs.
Consider the L4 array shown in the next Figure. The L4 array is denoted as L4(2^3).
L4 means the array requires 4 runs. 2^3 indicates that the design estimates up to three main effects at 2 levels each. The L4 array can be used to estimate three main effects using four runs provided that the twthree-factoro factor and three factor interactions can be ignored.
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)Teck Nam Ang
This set of slides explains in a simple manner the purpose of experiment, various strategies of experiment, how to plan and design experiment, and the handling of experimental data.
This document is intended to provide guidance for registration applications on the content and qualification of impurities in new drug substances produced by chemical syntheses and not previously registered in a region or member state.
Impurities in drug substance (ich q3 a)Bhanu Chava
This document discusses guidelines for classifying, reporting, controlling, and qualifying impurities in new drug substances. It defines types of impurities and provides thresholds for reporting, identifying, and qualifying impurities. The key points are:
- Impurities are classified as organic, inorganic, or residual solvents. Organic impurities can arise from starting materials, byproducts, or degradation.
- Identification thresholds determine which impurities must be identified and qualified. Impurities above reporting thresholds must be reported.
- Specifications list individual specified impurities and general limits for unspecified impurities.
- Qualification involves evaluating safety data for impurities at specified levels. Impurities may need further study if usual qualification thresholds
The document discusses key aspects of change control processes. It describes calculating theoretical, actual, and practical yields. It also covers reviewing production records before batch release and investigating discrepancies. Finally, it outlines the types, levels of approval, and steps of the change control process, including documenting requests, assessing impacts, planning implementation, and verifying changes.
The document discusses two examples of early experiments involving design of experiments principles:
1) During World War II, scientists simplified the complex factors involved in explosive detonation down to a cylinder expansion test with standardized materials and measurements to better study the fundamental mechanisms.
2) In 1747, James Lind conducted a controlled experiment providing different dietary supplements to groups of scurvy patients, finding those given oranges and lemons recovered while others did not, identifying citrus as a cure for scurvy. However, the experiment was not fully randomized and some treatments lacked scientific basis.
The document provides an overview of design of experiments (DOE) and factorial experiments. It defines key terms like factors, levels, treatments, responses, and noise. It explains the objectives of conducting experiments and the different types of experiments. It provides examples of 2-factor and 3-factor factorial experiments and how to analyze them. It discusses the principles of replication, randomization, and blocking. Finally, it demonstrates how to set up and analyze a general full factorial design with factors having more than two levels.
The document discusses ICH Q3D guidelines for controlling elemental impurities in pharmaceutical products. It defines elemental impurities as metals that have no therapeutic benefit and should be limited. The guidelines establish permitted daily exposures for 24 elements of concern and provide a risk-based approach to control impurities. Elements are classified based on their toxicity into Classes 1-3. The risk assessment process identifies potential sources of impurities and evaluates predicted levels. Control methods include modifying manufacturing processes, establishing specifications limits for materials and products, and selecting appropriate container systems. The guidelines provide options to convert permitted daily exposures into concentration limits for individual components and finished products.
The document discusses guidelines for controlling elemental impurities in pharmaceutical products according to ICH Q3D. It provides information on:
- Common sources of elemental impurities in drug products
- Classification of elements into categories based on their toxicity and likelihood of occurrence
- Methods for establishing permitted daily exposures (PDEs) for elements
- A risk-based approach to assessing and controlling elemental impurities that includes identifying potential sources, evaluating levels compared to PDEs, and documenting control plans
- Options for converting PDEs into concentration limits in drug products or components
The guidelines aim to replace qualitative heavy metal limits with quantitative control of specific elemental impurities shown to have no therapeutic benefit. Manufacturers must
FDA’s emphasis on quality by design began with the recognition that increased testing does not improve product quality (this has long been recognized in other industries).In order for quality to increase, it must be built into the product. To do this requires understanding how formulation and manufacturing process variables influence product quality.Quality by Design (QbD) is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.
This presentation - Part VI in the series- deals with the concepts of Design of Experiments. This presentation was compiled from material freely available from FDA , ICH , EMEA and other free resources on the world wide web.
Everything You Wanted to Know About Definitive Screening DesignsJMP software from SAS
An introduction to definitive screening designs (DSDs). These slides describe issues with standard screening designs and how to overcome these issues by using DSDs and orthogonally blocked DSD, first introduced by Bradley Jones of SAS and Christopher Nachtsheim of the Carlson School of Management, University of Minnesota. For information about using JMP software for design of experiments and DSDs, see http://www.jmp.com/applications/doe/
This document discusses common misconceptions about optimal experimental designs. It notes that while optimal designs are not always orthogonal, standard orthogonal textbook designs are optimal under certain models. Orthogonal designs also depend on the assumed model. The document introduces alias optimal designs as a new criterion that can reduce aliasing in optimal designs compared to traditional D-optimal designs. It provides examples of custom designs in JMP and concludes that optimal designs generally perform well across a range of models without requiring an exact pre-specified model.
LeanUX (lean user experience) experimentation has mostly focused on "A/B" testing. This presentation reviews how full and half factorial design of experiments might be used in Lean User Experience design.
The document discusses Taguchi screening designs, which are a type of experimental design used in product development to identify the main factors affecting a process using a minimal number of tests. It explains key terms like experimental design, screening design, and Taguchi method. The document compares screening designs to full factorials and lists advantages and disadvantages of each. It provides details on how to set up and analyze Taguchi screening designs, including determining variables and levels, selecting a screening design, setting up the test matrix, analyzing main effects plots, and confirming results. Resources on experimental design are also listed.
Principles of design of experiments (doe)20 5-2014Awad Albalwi
This document discusses experimental design and optimization. It defines key terms like factors, responses, and residuals. It explains that experimental design is used to systematically examine problems in research, development and production. Factorial design is introduced as a method to study the effects of all factors and interactions on responses. The document provides an example experimental design to investigate if playing violent video games causes violent behavior. It outlines defining the population, randomly selecting a sample, using control and experimental conditions, measuring dependent variables, and comparing results to draw conclusions.
The document discusses experimental research design. It covers key concepts like causality, conditions for causality, validity, and extraneous variables. It also describes different types of experimental designs including pre-experimental, true experimental, quasi-experimental, and statistical designs. Examples are provided to illustrate different designs like randomized block and Latin square designs. Limitations of experimentation are also briefly discussed.
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Karthikeyan Kannappan
The Taguchi method involves reducing the variation in a process through robust design of experiments. The experimental design proposed by Taguchi involves using orthogonal arrays to organize the parameters affecting the process and the levels at which they should be varies. Instead of having to test all possible combinations like the factorial design, the Taguchi method tests pairs of combinations. The Taguchi arrays can be derived or looked up. Small arrays can be drawn out manually; large arrays can be derived from deterministic algorithms. Generally, arrays can be found online. The arrays are selected by the number of parameters (variables) and the number of levels (states).
In this paper, the specific steps involved in the application of the Taguchi method will be described with example.
This document provides an overview of basic design of experiments (DOE). It discusses how DOE is a more effective approach to experimentation than traditional trial and error or one-factor-at-a-time methods. The document reviews full and fractional factorial experimental designs and provides an example exercise involving optimization of a paper helicopter design through experimental testing. The overall goal is to introduce practitioners to DOE methodology and its benefits for process and product improvement.
Causal-comparative research attempts to identify cause-and-effect relationships by comparing two or more groups that differ on some independent variable. It is a nonexperimental method used to explore potential causes of existing differences between groups. Researchers select groups that already differ on the independent variable rather than manipulating the variable. Common threats to validity include lack of randomization and inability to control for confounding variables. Analysis typically involves comparing means and using t-tests or ANOVAs to determine if differences between groups are statistically significant.
This presentation was given live at JMP Discovery Summit 2013 in San Antonio, Texas, USA. To sign up to attend this year's conference, visit http://jmp.com/summit
The Cult of Statistical Significance: Science after Gosset, Fisher, and Mat...Philipp Upravitelev
The contents of these slides—including
the quotes—are from S.T. Ziliak’s and
D.N. McCloskey’s The Cult of
Statistical Significance: How the
Standard Error Costs Us Jobs, Justice,
and Lives (2008, University of Michigan
Press); Ziliak’s “Guinnessometrics:
The Economic Foundation of
‘Student’s’ t,” Journal of Economic
Perspectives (Fall 2008); and Ziliak’s
“Matrixx v. Siracusano and Student v.
Fisher,” Significance 8 (3), 2011, Royal
Statistical Society and ASA.
Carmona Estates is a large, 60-hectare residential development located near the Carmona exit of the South Luzon Expressway in Cavite, Philippines. The development has nine phases and features pocket parks and open spaces for children. It is about 30 minutes from Makati and accessible to public transportation. The development offers several house and lot options ranging from 52 to 104 square meters, each with bedrooms, bathrooms, and provisions for parking. Amenities include a chapel and clubhouse with swimming pool. Financing options are available through banks or an in-house scheme.
Uganda: Food processing and agribusiness investment opportunitiesS. KOUADIO
This webinar package provides information about investing and trading opportunities in Uganda through three sessions. Session 1 introduces Uganda through prerecorded presentations on its agriculture sector, market analysis, and energy sector investments. Session 2 focuses on Uganda's priority investment projects with a live presentation and Q&A. Session 3 discusses project implementation with a case study and risk mitigation solutions. The webinars aim to help companies understand and capitalize on opportunities in Uganda's agribusiness, food processing, and retail sectors.
Exploratory testing is a formal approach of testing that involves simultaneous learning, test schematizing, and test execution. The testers explore the application and learn about its functionalities by discovery and learning method. They then, use exploratory test charters to direct, record and keep track of the exploratory test session’s observations. It is a hands-on procedure in which testers perform minimum planning and maximum test exploration.
Consistently delivering and maintaining well performing applications doesn't just happen, it requires a solid architecture, sound development, continual attention, diligence and expertise. It also requires appropriate testing, not simply of release-candidate builds, but of designs, units, integrations, and physical components... both during development and in production. The question is, how can a team accomplish all of that under all of today's pressure to deliver quickly and cheaply?
Join Scott Barber for this Keynote Address to hear about what successful organizations are doing to consistently deliver well performing applications, to learn the underlying principles and practices that enable those organizations to create, test, and maintain those well performing applications without breaking either the budget or the schedule, and what the key items are that virtually every team can implement right away, to dramatically improve the consistency and overall performance of their applications.
The purpose of "stress" screening such as environmental stress screening (ESS) or highly accelerated stress screening (HASS) is to precipitate failures in weak or defective populations using some load (stress) condition(s) without reducing the required useful life of the product
Optimizing the project portfolio oracle Instantis enterprise track and crys...p6academy
The document discusses how Oracle's Crystal Ball software can help optimize project portfolio selection by evaluating large numbers of combinations to recommend the best choice of projects. It provides examples of how Crystal Ball allows automated what-if analysis and optimization to evaluate alternative strategies and tradeoffs more efficiently than manual methods. The software finds optimal project portfolios that balance various objectives such as costs, benefits and risks.
CON8438_Hendrickson-Oracle and Accenture Well Delivery Solution Presentation ...William Hendrickson
The document summarizes a presentation about driving improvements across the oil and gas value chain through integrated well delivery. It discusses challenges such as increased complexity, poor execution, and loss of control leading to poor business results. It then outlines benefits of an integrated well delivery solution such as reducing time to first oil by 15% and drilling costs by 20%. Finally, it describes key elements of the Oracle and Accenture integrated well delivery solution such as integrated activity planning and scheduling, resource optimization, risk mitigation, and cost containment.
The Survey Says: Testers Spend Their Time Doing...TechWell
How can testers contribute more to the success of their project and their company? How can they focus on asking the right questions, improving test planning and design, and finding defects so the business releases a quality product―even though there’s always one more fire to extinguish or one more request to fulfill? There aren’t enough hours in the day to do it all. Join Al Wagner as he reveals recent survey results showing where testers actually spend their time and where testers think their time would be better spent. Compare your own experience with what 250 test professionals from around the world reported. You may be surprised how prevalent testing challenges really are. Learn what techniques and technologies are available to help today’s test professionals execute what they were actually hired to do—test software. Return to your organization with an increased understanding of how other testers are dealing with their testing bottlenecks and what activities your peers view as the best use of their valuable time.
The document discusses how test axioms can be used to advance testing practices. It introduces 16 proposed test axioms grouped into stakeholder, design, and delivery axioms. The axioms represent critical thinking processes for testing any system. The document discusses how the axioms can help testers design test strategies, assess improvement opportunities, and define needed skills. It also proposes a "first equation of testing" that separates axioms, context, values, and thinking to allow for different valid approaches. Additionally, the concept of "quantum testing" is introduced to discuss assigning significance to tests rather than defining their value, which can only be determined by stakeholders.
Elizabeth Snowdon is a senior business analyst and consultant specializing in user-centered design with over 12 years of experience. Her presentation discusses prototyping and usability testing, noting that usability testing should occur throughout the product development lifecycle to identify and address usability issues. She outlines the benefits of usability testing and prototyping, such as creating more useful, efficient and satisfying products for users. The presentation provides guidance on planning, conducting and analyzing usability tests, including determining test objectives, recruiting representative users, developing test tasks and metrics to collect.
This document presents a research plan for a case study to reduce food waste sent to landfills. The plan outlines objectives to analyze alternative technologies to reduce waste and conduct a cost-benefit analysis. It describes the methodology, including developing selection and screening criteria to evaluate alternatives and their effectiveness. Risks such as technical, cost, schedule, and programmatic challenges are also discussed. A schedule with deliverables is provided. The document then describes the decision analysis methods of TOPSIS and SAW that will be used to evaluate alternatives, including normalizing and weighting the decision matrix.
Web Performance Analysis - TCF Pro 2009Guy Ferraiolo
This document surveys web performance analysis. It discusses goals like understanding performance results and saving time and money. Key concepts discussed include reducing uncertainty through iterative testing and analysis. The document provides advice on defining processes, using tools appropriately, and designing tests to gain the most insight. It emphasizes that performance analysis requires a serious, long-term investment but can provide meaningful results.
A test strategy is the set of ideas that guides your test design. It's what explains why you test this instead of that, and why you test this way instead of that way. Strategic thinking matters because testers must make quick decisions about what needs testing right now and what can be left alone. You must be able to work through major threads without being overwhelmed by tiny details. James Bach describes how test strategy is organized around risk but is not defined before testing begins. Rather, it evolves alongside testing as we learn more about the product. We start with a vague idea of our strategy, organize it quickly, and document as needed in a concise way. In the end, the strategy can be as formal and detailed as you want it to be. In the beginning, though, we start small. If you want to focus on testing and not paperwork, this approach is for you.
The document provides an introduction to approaches to software testing presented by Scott Barber, Chief Technologist at PerfTestPlus, Inc. It includes an overview of Barber's background and expertise in software testing. The agenda outlines discussing different testing schools, life cycles, techniques and practices, and putting them together. It describes doing a self-categorization activity where attendees vote on where their projects fit in terms of schools, life cycles, and techniques.
A presentation that provides an overview of software testing approaches including "schools" of software testing and a variety of testing techniques and practices.
1_Design and Analysis of Experiment_Data Science.pptxdeepak667128
The document discusses strategies for designing experiments, including one-factor-at-a-time (OFAT) experiments and factorial designs. It provides examples of factors and responses for experiments in various domains. The key advantages of factorial designs over OFAT are that they provide information on interactions between factors and more efficient estimates of factor effects.
The document introduces performance testing and provides an overview of key concepts. It discusses why performance testing is important to ensure an application's speed, scalability, stability, and user experience. The document also defines performance validation, testing, and engineering and contrasts their differences. Finally, it outlines the typical methodology for performance engineering including evaluating systems, developing test assets, analyzing results, and tuning performance.
Introduction to Operations Research with basic concepts along with Models in Operation Research also addressed.
Subscribe to Vision Academy YouTube Channel
https://www.youtube.com/channel/UCjzpit_cXjdnzER_165mIiw
Sharing some test heuristics that you can use in different apps your testing!
For more presentation slides related to testing and automation, visit us at qeisthenewqa.com
Common testing pitfalls NextGen Testing Conference - 2014-09-18Donald Firesmith
An introduction to a taxonomy of 128 commonly occurring system and software testing pitfalls in 18 categories. This is an update including changes since the book Common System and Software Testing Pitfalls was published in January 2014. This is much more up to date than earlier versions that are being downloaded from SharePoint.
Similar to Exploring Best Practises in Design of Experiments (20)
The Straight Way to a Final Result: Mixture Design of ExperimentsJMP software from SAS
Running experiments is an essential part of all development, improvement, upscaling and research. Very often, experiments are run following traditional legacy designs. Only one factor gets changed over a series of experiments. Single-factor experiments are not possible with mixture designs as all the components have to add up to the total.
This presentation introduces Statistical Discovery, a process that allows you to work with data to discover new, useful, insights that drive cycles of learning. After a brief overview to introduce the concept, an example involving property prices in the US will be used to demonstrate the how the process works in practice. Through this example we also exemplify the skills and aptitudes required to exercise the process successfully.
Bilder sagen mehr als Zahlenreihen: Wie Sie Ihre Excel Daten mit JMP graphisch analysieren können.
A picture says more than a speadsheet. See how you can visually analyze your excel data.
Would you like greater confidence that the models you build are genuinely useful and can drive rational decisions? This slideshow will show how to build the most useful models that fully exploit all the information in your data, simply and easily.
Join us for an upcoming live webcast to learn more about using JMP: http://www.jmp.com/uk/about/events/webcasts/
And if you'd like to try JMP, here's how: http://www.jmp.com/uk/software/try-jmp.shtml?product=jmp&ref=top
The document discusses how JMP statistical software can help ethanol producers improve quality, increase yield, and optimize experimentation. It provides examples of how JMP was used to identify a contamination source, screen for factors impacting yield, and design an efficient experiment. JMP allows users to quickly visualize, analyze, model, and report on data to speed up the time to discovery. A free trial of JMP is available for ethanol producers to learn more.
See how you can use statistical analysis to conduct useful and effective consumer and marketing research. These slides were used in a seminar held in the UK at The Shard. To see upcoming seminars, visit http://www.jmp.com/uk/about/events/conferences/
Slides accompanying Malcolm Moore’s 2014 webcast on statistical and predictive modelling where he demonstrates JMP as an effective tool for exploratory data analysis, and JMP Pro as an expert modelling tool that scales to any number of Xs and Ys, is effective with messy data, and reduces the risk of selecting the wrong model. Watch the webcasts at http://www.jmp.com/uk/about/events/webcasts/
An overview of the basic principles of system evaluation, measurement system analysis, Gauge R&R, process monitoring and the methods for evaluating the measurement process popularized by Donald J. Wheeler. These slides accompanied Peter Bartell’s JMP webcast on Evaluating & Monitoring Your Process Using MSA & SPC. Watch the webcasts at http://www.jmp.com/mastering
These slides provide an overview of the basics of design of experiments. They also describe and give examples of categorical and continuous factors and responses, discrete numeric and mixture variables, and blocking factors. The slides were presented live and in recorded videos as part of the Mastering JMP webcast series. Watch the webcasts at http://www.jmp.com/mastering
This presentation was given live at JMP Discovery Summit 2012 in Cary, North Carolina, USA.More information about statistical modeling is available at http://www.jmp.com/applications/statistics/
Visual Analytic Approaches for the Analysis of Spontaneously Reported Adverse...JMP software from SAS
This document discusses approaches for analyzing spontaneously reported adverse events from post-market drug surveillance. It describes how clinical trials provide an incomplete safety profile and how data from post-market use can reveal rare or long-term safety issues. Statistical methods like disproportionality analysis are used to detect unexpected drug-event combinations in spontaneous reporting data by comparing the frequency of reports for a drug-event pair to what would be expected based on overall reporting rates. Stratifying the data by patient characteristics can improve the accuracy of these analyses. Signals of disproportionate reporting are defined as drug-event pairs where the confidence or credible interval for their association exceeds a threshold value.
This talk was presented live at JMP Discovery Summit 2012 in Cary, North Carolina, USA. More information about design of experiments is available at http://www.jmp.com/applications/doe/
This slide deck presents an introduction to statistical modeling by Don McCormack of JMP. Don presents at Building Better Models seminars throughout the world. Upcoming complimentary US seminars are listed here: http://jmp.com/about/events/seminars/
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMPJMP software from SAS
This presentation was given live at JMP Discovery Summit 2013 in San Antonio, Texas, USA. To sign up to attend this year's conference, visit http://jmp.com/summit
This document provides an overview of resampling techniques including the bootstrap, permutation tests, and parametric bootstrap. It discusses how these methods can be used to estimate variances and confidence intervals for statistics. It also covers how the bootstrap can be used for hypothesis testing and improving predictions through techniques like bagging. Examples are provided for implementing various resampling methods in JMP using JSL scripts.
This presentation was given live at JMP Discovery Summit 2013 in San Antonio, Texas, USA. To sign up to attend this year's conference, visit http://jmp.com/summit
OpenMetadata Community Meeting - 5th June 2024OpenMetadata
The OpenMetadata Community Meeting was held on June 5th, 2024. In this meeting, we discussed about the data quality capabilities that are integrated with the Incident Manager, providing a complete solution to handle your data observability needs. Watch the end-to-end demo of the data quality features.
* How to run your own data quality framework
* What is the performance impact of running data quality frameworks
* How to run the test cases in your own ETL pipelines
* How the Incident Manager is integrated
* Get notified with alerts when test cases fail
Watch the meeting recording here - https://www.youtube.com/watch?v=UbNOje0kf6E
Neo4j - Product Vision and Knowledge Graphs - GraphSummit ParisNeo4j
Dr. Jesús Barrasa, Head of Solutions Architecture for EMEA, Neo4j
Découvrez les dernières innovations de Neo4j, et notamment les dernières intégrations cloud et les améliorations produits qui font de Neo4j un choix essentiel pour les développeurs qui créent des applications avec des données interconnectées et de l’IA générative.
Most important New features of Oracle 23c for DBAs and Developers. You can get more idea from my youtube channel video from https://youtu.be/XvL5WtaC20A
DDS Security Version 1.2 was adopted in 2024. This revision strengthens support for long runnings systems adding new cryptographic algorithms, certificate revocation, and hardness against DoS attacks.
A Study of Variable-Role-based Feature Enrichment in Neural Models of CodeAftab Hussain
Understanding variable roles in code has been found to be helpful by students
in learning programming -- could variable roles help deep neural models in
performing coding tasks? We do an exploratory study.
- These are slides of the talk given at InteNSE'23: The 1st International Workshop on Interpretability and Robustness in Neural Software Engineering, co-located with the 45th International Conference on Software Engineering, ICSE 2023, Melbourne Australia
Using Query Store in Azure PostgreSQL to Understand Query PerformanceGrant Fritchey
Microsoft has added an excellent new extension in PostgreSQL on their Azure Platform. This session, presented at Posette 2024, covers what Query Store is and the types of information you can get out of it.
Measures in SQL (SIGMOD 2024, Santiago, Chile)Julian Hyde
SQL has attained widespread adoption, but Business Intelligence tools still use their own higher level languages based upon a multidimensional paradigm. Composable calculations are what is missing from SQL, and we propose a new kind of column, called a measure, that attaches a calculation to a table. Like regular tables, tables with measures are composable and closed when used in queries.
SQL-with-measures has the power, conciseness and reusability of multidimensional languages but retains SQL semantics. Measure invocations can be expanded in place to simple, clear SQL.
To define the evaluation semantics for measures, we introduce context-sensitive expressions (a way to evaluate multidimensional expressions that is consistent with existing SQL semantics), a concept called evaluation context, and several operations for setting and modifying the evaluation context.
A talk at SIGMOD, June 9–15, 2024, Santiago, Chile
Authors: Julian Hyde (Google) and John Fremlin (Google)
https://doi.org/10.1145/3626246.3653374
Artificia Intellicence and XPath Extension FunctionsOctavian Nadolu
The purpose of this presentation is to provide an overview of how you can use AI from XSLT, XQuery, Schematron, or XML Refactoring operations, the potential benefits of using AI, and some of the challenges we face.
UI5con 2024 - Keynote: Latest News about UI5 and it’s EcosystemPeter Muessig
Learn about the latest innovations in and around OpenUI5/SAPUI5: UI5 Tooling, UI5 linter, UI5 Web Components, Web Components Integration, UI5 2.x, UI5 GenAI.
Recording:
https://www.youtube.com/live/MSdGLG2zLy8?si=INxBHTqkwHhxV5Ta&t=0
Flutter is a popular open source, cross-platform framework developed by Google. In this webinar we'll explore Flutter and its architecture, delve into the Flutter Embedder and Flutter’s Dart language, discover how to leverage Flutter for embedded device development, learn about Automotive Grade Linux (AGL) and its consortium and understand the rationale behind AGL's choice of Flutter for next-gen IVI systems. Don’t miss this opportunity to discover whether Flutter is right for your project.
8 Best Automated Android App Testing Tool and Framework in 2024.pdfkalichargn70th171
Regarding mobile operating systems, two major players dominate our thoughts: Android and iPhone. With Android leading the market, software development companies are focused on delivering apps compatible with this OS. Ensuring an app's functionality across various Android devices, OS versions, and hardware specifications is critical, making Android app testing essential.
Do you want Software for your Business? Visit Deuglo
Deuglo has top Software Developers in India. They are experts in software development and help design and create custom Software solutions.
Deuglo follows seven steps methods for delivering their services to their customers. They called it the Software development life cycle process (SDLC).
Requirement — Collecting the Requirements is the first Phase in the SSLC process.
Feasibility Study — after completing the requirement process they move to the design phase.
Design — in this phase, they start designing the software.
Coding — when designing is completed, the developers start coding for the software.
Testing — in this phase when the coding of the software is done the testing team will start testing.
Installation — after completion of testing, the application opens to the live server and launches!
Maintenance — after completing the software development, customers start using the software.
E-Invoicing Implementation: A Step-by-Step Guide for Saudi Arabian CompaniesQuickdice ERP
Explore the seamless transition to e-invoicing with this comprehensive guide tailored for Saudi Arabian businesses. Navigate the process effortlessly with step-by-step instructions designed to streamline implementation and enhance efficiency.
Zoom is a comprehensive platform designed to connect individuals and teams efficiently. With its user-friendly interface and powerful features, Zoom has become a go-to solution for virtual communication and collaboration. It offers a range of tools, including virtual meetings, team chat, VoIP phone systems, online whiteboards, and AI companions, to streamline workflows and enhance productivity.
WhatsApp offers simple, reliable, and private messaging and calling services for free worldwide. With end-to-end encryption, your personal messages and calls are secure, ensuring only you and the recipient can access them. Enjoy voice and video calls to stay connected with loved ones or colleagues. Express yourself using stickers, GIFs, or by sharing moments on Status. WhatsApp Business enables global customer outreach, facilitating sales growth and relationship building through showcasing products and services. Stay connected effortlessly with group chats for planning outings with friends or staying updated on family conversations.
Takashi Kobayashi and Hironori Washizaki, "SWEBOK Guide and Future of SE Education," First International Symposium on the Future of Software Engineering (FUSE), June 3-6, 2024, Okinawa, Japan
SMS API Integration in Saudi Arabia| Best SMS API ServiceYara Milbes
Discover the benefits and implementation of SMS API integration in the UAE and Middle East. This comprehensive guide covers the importance of SMS messaging APIs, the advantages of bulk SMS APIs, and real-world case studies. Learn how CEQUENS, a leader in communication solutions, can help your business enhance customer engagement and streamline operations with innovative CPaaS, reliable SMS APIs, and omnichannel solutions, including WhatsApp Business. Perfect for businesses seeking to optimize their communication strategies in the digital age.